|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
11
|
|
pubmed:dateCreated |
2008-10-29
|
|
pubmed:abstractText |
We studied whether measurement of the free beta subunit of human chorionic gonadotropin (hCGbeta) in serum offers additional diagnostic information compared to determination of intact hCG alone in testicular cancer.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Nov
|
|
pubmed:issn |
1530-8561
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
54
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1840-3
|
|
pubmed:meshHeading |
pubmed-meshheading:18787014-Chorionic Gonadotropin, beta Subunit, Human,
pubmed-meshheading:18787014-Humans,
pubmed-meshheading:18787014-Male,
pubmed-meshheading:18787014-Recurrence,
pubmed-meshheading:18787014-Seminoma,
pubmed-meshheading:18787014-Sensitivity and Specificity,
pubmed-meshheading:18787014-Testicular Neoplasms,
pubmed-meshheading:18787014-Tumor Markers, Biological
|
|
pubmed:year |
2008
|
|
pubmed:articleTitle |
Free beta-subunit of human chorionic gonadotropin in serum is a diagnostically sensitive marker of seminomatous testicular cancer.
|
|
pubmed:affiliation |
Department of Clinical Chemistry, Helsinki University Central Hospital and Helsinki University, Helsinki, Finland. anna.lempiainen@helsinki.fi
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
